Testing PG-033 in healthy adults: a first-in-human study
Part of Skin clinical trials.
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in good general health, with no chronic or serious medical conditions.
- You have not taken any prescription or over-the-counter medications (including supplements) in the last 2 weeks.
- You do not smoke more than 5 cigarettes a day, and you can avoid smoking during the study.
- You are willing to use effective birth control or avoid pregnancy for 3 months after the study ends.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests increasing doses of a new experimental drug (PG-033) in healthy people to understand how it works in the body and check for side effects. It helps researchers determine safe dosing before testing it in patients with medical conditions.
This study tests a new drug (BG-A3004) for safety in healthy volunteers and people with certain skin conditions like alopecia areata, cutaneous lichen planus, or vitiligo. It helps find out if the drug is safe and how the body processes it.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new medicine called LH-001 in healthy volunteers to see if it is safe. You will receive either the medicine or a placebo (a dummy pill) and stay overnight for monitoring.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
Hear when a new Lichen Simplex Chronicus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.